BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21968309)

  • 1. [The effects of inoculation route and adjuvant type on the immunizing potency of CVB3 VP1 protein].
    Wen C; Gao ZY; Lan JM; Yan LJ; Chuai X; Li J; Li W; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1086-9. PubMed ID: 21968309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C3d enhances immune response to the secreted form of Coxsackie virus B3 VP1 DNA vaccine].
    Zhao N; Han XY; Wang XL; Li J; Li W; Xie LX; Li L; Wang YX
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2561-3. PubMed ID: 18067834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune effects of four coxsackievirus B3 VP1 DNA fusion vaccines in mice].
    Liu GX; Lan JM; Chuai X; Gao ZY; Jin YH; Zhang YH; Xie LX; Yin CF; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):103-6. PubMed ID: 20230664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on combined immunization of rAd/MDC-VP1 and pcDNA3/MDC-VP1 against Coxsackievirus B3 challenge in mice].
    Yan LJ; Gao ZY; Li J; Lan JM; Jin YH; Xie LX; Chuai X; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):228-31. PubMed ID: 22394627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
    Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fusion expression of O type foot-and-mouth diseases virus VP1 gene and HSP70 gene and induction of immune responses in mice].
    Su CX; Duan XG; Wang XQ; Ren XF; Cao RB; Zhou B; Chen PY
    Sheng Wu Gong Cheng Xue Bao; 2006 Sep; 22(5):733-6. PubMed ID: 17037194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prokaryotic expression, protein purification and reactivity analysis of the VP1 and its C terminus of a South African isolate of FMDV serotype SAT2].
    Gao SD; Chang HY; Du JZ; Shao JJ; Cong GZ; Lin T; Han XQ; Xie QG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):631-4. PubMed ID: 20619084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
    Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
    J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of the eukaryotic expression vector with IL-2 gene and VP2 gene of PPV and research on immunogenicity].
    Cui BA; Wei ZY; Wang XB; Huang KH; Jin XX; Dong ZJ; Zheng LL
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):425-30. PubMed ID: 16755922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y; Zhang DM; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
    Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
    Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of the recombinant adenovirus expressing the CVB3 sVP1-C3d3 protein and study on its immunological effects in mice].
    Li J; Li J; Xian X; Liu GX; Lan JM; Jin YH; Xie LX; Zhang H; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):47-50. PubMed ID: 21208565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein VP1 for developing subunit vaccine material against hepatitis A virus.
    Jang KO; Park JH; Lee HH; Chung DK; Kim W; Chung IS
    Protein Expr Purif; 2014 Aug; 100():1-9. PubMed ID: 24816194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route.
    Qi X; Lu Q; Hu J; Xiong S
    Microb Cell Fact; 2019 Apr; 18(1):66. PubMed ID: 30947747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
    Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
    Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.